Literature DB >> 22005993

Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles.

George R Thompson1, Derek Bays, Stuart H Cohen, Demosthenes Pappagianis.   

Abstract

The use of voriconazole, a trifluorinated antifungal, has been associated with the development of fluoride excess and periostitis/exostoses. We evaluated a cohort of patients on long-term triazole therapy and found that other fluorinated triazoles (fluconazole and posaconazole) conferred no risk for the development of hyperfluorosis and its complications in our cohort.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22005993      PMCID： PMC3256030          DOI： 10.1128/AAC.05275-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.

Authors:  Robert A Wermers; Kay Cooper; Raymund R Razonable; Paul J Deziel; Gary M Whitford; Walter K Kremers; Thomas P Moyer
Journal:  Clin Infect Dis       Date:  2011-01-16       Impact factor: 9.079

Review 2.  Medication-induced periostitis in lung transplant patients: periostitis deformans revisited.

Authors:  Lina Chen; Michael E Mulligan
Journal:  Skeletal Radiol       Date:  2010-07-22       Impact factor: 2.199

3.  Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.

Authors:  Asad Ayub; Charles V Kenney; Fergus E McKiernan
Journal:  J Clin Rheumatol       Date:  2011-03       Impact factor: 3.517

4.  Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity.

Authors:  Daniel D Miller; Edward W Cowen; Josephine C Nguyen; Timothy H McCalmont; Lindy P Fox
Journal:  Arch Dermatol       Date:  2010-01-18

Review 5.  Intake and metabolism of fluoride.

Authors:  G M Whitford
Journal:  Adv Dent Res       Date:  1994-06

6.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079
  6 in total
  15 in total

Review 1.  An update on drug-induced arthritis.

Authors:  Marwan H Adwan
Journal:  Rheumatol Int       Date:  2016-03-21       Impact factor: 2.631

Review 2.  Infectious Complications in Patients With Chronic Granulomatous Disease.

Authors:  Nicholas Bennett; Paul J Maglione; Benjamin L Wright; Christa Zerbe
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

3.  Mimicking Multiple Myeloma: Voriconazole-Induced Hyperfluorosis and Bone Lesions.

Authors:  Kristen D Kelley; George R Thompson; Paul Aronowitz
Journal:  J Gen Intern Med       Date:  2019-11-12       Impact factor: 5.128

4.  Voriconazole-related periostitis presenting on magnetic resonance imaging.

Authors:  Derik L Davis
Journal:  Clin Cases Miner Bone Metab       Date:  2015 Jan-Apr

Review 5.  Pulmonary Coccidioidomycosis: A Case Report and Literature Review.

Authors:  Tadas Alčauskas; Birutė Zablockienė; Rolandas Zablockis; Linas Svetikas; Laura Bilotaitė; Ligita Jančorienė
Journal:  Medicina (Kaunas)       Date:  2022-05-12       Impact factor: 2.948

6.  Spectrum of voriconazole-associated periostitis in clinical characteristics, diagnosis and management.

Authors:  Zuojun Li; Cuifang Wu; Chunjiang Wang; Zhenzhen Deng
Journal:  Infection       Date:  2022-03-14       Impact factor: 7.455

7.  Plasma fluoride level as a predictor of voriconazole-induced periostitis in patients with skeletal pain.

Authors:  Woo J Moon; Erica L Scheller; Anupam Suneja; Jacob A Livermore; Anurag N Malani; Varsha Moudgal; Lisa E Kerr; Eric Ferguson; David M Vandenberg
Journal:  Clin Infect Dis       Date:  2014-07-03       Impact factor: 9.079

8.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

Review 9.  Voriconazole-induced periostitis: a new rheumatic disorder.

Authors:  Marwan H Adwan
Journal:  Clin Rheumatol       Date:  2016-07-04       Impact factor: 2.980

10.  Last generation triazoles for imported eumycetoma in eleven consecutive adults.

Authors:  Yoann Crabol; Sylvain Poiree; Marie-Elisabeth Bougnoux; Christophe Maunoury; Stéphane Barete; Valérie Zeller; Cédric Arvieux; Samuel Pineau; Karima Amazzough; Marc Lecuit; Fanny Lanternier; Olivier Lortholary
Journal:  PLoS Negl Trop Dis       Date:  2014-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.